Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Quarterly figures for Reviva Pharmaceuticals Holdings, Inc., with source filings when available.
31 quarters. May 31, 2018 to Jun 30, 2026. mixed units.
Reviva Pharmaceuticals Holdings, Inc. has filed its 10-Q within 43 to 45 days of period end across its last 8 quarters. The 10-K runs 65 to 106 days.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 12, 2026 | 43 d | 10-Q | — | — | — | |
| Mar 31, 2026 |
| May 13, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| — |
| — |
| — |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 30, 2026 · pre-market | Mar 30, 2026 | 89 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · after-hours | Nov 13, 2025 | 44 d | 10-Q | — | — | — | |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 · after-hours | Aug 14, 2025 | 45 d | 10-Q | — | — | — | |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 · after-hours | May 15, 2025 | 45 d | 10-Q | — | — | — | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 31, 2025 · after-hours | Apr 3, 2025 | 93 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | — | — | — | |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 · pre-market | Aug 14, 2024 | 45 d | 10-Q | — | — | — | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · pre-market | May 14, 2024 | 44 d | 10-Q | — | — | — | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Apr 15, 2024 | 106 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 · after-hours | Nov 14, 2023 | 45 d | 10-Q | — | — | — | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · after-hours | Aug 14, 2023 | 45 d | 10-Q | — | — | — | |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 · after-hours | May 15, 2023 | 45 d | 10-Q | — | — | — | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 30, 2023 · pre-market | Mar 30, 2023 | 89 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · after-hours | Nov 14, 2022 | 45 d | 10-Q | — | — | — | |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 · after-hours | Aug 15, 2022 | 46 d | 10-Q | — | — | — | |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 · after-hours | May 16, 2022 | 46 d | 10-Q | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 15, 2022 · after-hours | Mar 15, 2022 | 74 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | — | — | -$0.12 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | — | — | -$0.12 | |
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | — | — | -$0.10 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 22, 2021 | 81 d | 10-K | — | — | — | |
| Q2 2020 | Aug 31, 2020 | — | Oct 14, 2020 | 44 d | 10-Q | — | — | -$0.19 | |
| Q1 2020 | May 31, 2020 | — | Jul 7, 2020 | 37 d | 10-Q | — | — | -$0.09 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q3 2019 | Nov 30, 2019 | — | Jan 10, 2020 | 41 d | 10-Q | — | — | -$0.05 | |
| Q2 2019 | Aug 31, 2019 | — | Oct 8, 2019 | 38 d | 10-Q | — | — | -$0.02 | |
| Q1 2019 | May 31, 2019 | — | Jul 3, 2019 | 33 d | 10-Q | — | — | -$0.01 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q3 2018 | Nov 30, 2018 | — | Jan 9, 2019 | 40 d | 10-Q | — | — | -$0.02 | |
| Q2 2018 | Aug 31, 2018 | — | Oct 11, 2018 | 41 d | 10-Q | — | — | $0.00 | |
| Q1 2018 | May 31, 2018 | — | — | — | — | — | — | -$0.01 | |
